Nils R. Winter,Julian Blanke,Ramona Leenings,Jan Ernsting,Lukas Fisch,Kelvin Sarink,Carlotta Barkhau,Daniel Emden,Katharina Thiel,Kira Flinkenflügel,Alexandra Winter,Janik Goltermann,Susanne Meinert,Katharina Dohm,Jonathan Repple,Marius Gruber,Elisabeth J. Leehr,Nils Opel,Dominik Grotegerd,Ronny Redlich,Robert Nitsch,Jochen Bauer,Walter Heindel,Joachim Gross,Benjamin Risse,Till F. M. Andlauer,Andreas J. Forstner,Markus M. Nöthen,Marcella Rietschel,Stefan G. Hofmann,Julia-Katharina Pfarr,Lea Teutenberg,Paula Usemann,Florian Thomas-Odenthal,Adrian Wroblewski,Katharina Brosch,Frederike Stein,Andreas Jansen,Hamidreza Jamalabadi,Nina Alexander,Benjamin Straube,Igor Nenadić,Tilo Kircher,Udo Dannlowski,Tim Hahn

Abstract:Importance Biological psychiatry aims to understand mental disorders in terms of altered neurobiological pathways. However, for one of the most prevalent and disabling mental disorders, major depressive disorder (MDD), no informative biomarkers have been identified. Objective To evaluate whether machine learning (ML) can identify a multivariate biomarker for MDD. Design, Setting, and Participants This study used data from the Marburg-Münster Affective Disorders Cohort Study, a case-control clinical neuroimaging study. Patients with acute or lifetime MDD and healthy controls aged 18 to 65 years were recruited from primary care and the general population in Münster and Marburg, Germany, from September 11, 2014, to September 26, 2018. The Münster Neuroimaging Cohort (MNC) was used as an independent partial replication sample. Data were analyzed from April 2022 to June 2023. Exposure Patients with MDD and healthy controls. Main Outcome and Measure Diagnostic classification accuracy was quantified on an individual level using an extensive ML-based multivariate approach across a comprehensive range of neuroimaging modalities, including structural and functional magnetic resonance imaging and diffusion tensor imaging as well as a polygenic risk score for depression. Results Of 1801 included participants, 1162 (64.5%) were female, and the mean (SD) age was 36.1 (13.1) years. There were a total of 856 patients with MDD (47.5%) and 945 healthy controls (52.5%). The MNC replication sample included 1198 individuals (362 with MDD [30.1%] and 836 healthy controls [69.9%]). Training and testing a total of 4 million ML models, mean (SD) accuracies for diagnostic classification ranged between 48.1% (3.6%) and 62.0% (4.8%). Integrating neuroimaging modalities and stratifying individuals based on age, sex, treatment, or remission status does not enhance model performance. Findings were replicated within study sites and also observed in structural magnetic resonance imaging within MNC. Under simulated conditions of perfect reliability, performance did not significantly improve. Analyzing model errors suggests that symptom severity could be a potential focus for identifying MDD subgroups. Conclusion and Relevance Despite the improved predictive capability of multivariate compared with univariate neuroimaging markers, no informative individual-level MDD biomarker—even under extensive ML optimization in a large sample of diagnosed patients—could be identified.

More Alike than Different: Quantifying Deviations of Brain Structure and Function in Major Depressive Disorder across Neuroimaging Modalities

Biotypes of major depressive disorder: Neuroimaging evidence from resting-state default mode network patterns.

Identifying Subgroups of Major Depressive Disorder Using Brain Structural Covariance Networks and Mapping of Associated Clinical and Cognitive Variables

Connectome Analysis of Functional and Structural Hemispheric Brain Networks in Major Depressive Disorder

Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group

Molecular, Functional, and Structural Imaging of Major Depressive Disorder

Altered Resting-State Dynamic Functional Brain Networks in Major Depressive Disorder: Findings from the REST-meta-MDD Consortium

A Systematic Evaluation of Machine Learning–Based Biomarkers for Major Depressive Disorder

AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationale

Twenty-Five Cohorts of Major Depressive Disorder in China: Evidence for Reduced But Not Enhanced Default Mode Network Functional Connectivity

Large Individual Differences in Functional Connectivity in the Context of Major Depression and Antidepressant Pharmacotherapy

Severity of current depression and remission status are associated with structural connectome alterations in major depressive disorder

Altered brain dynamic in major depressive disorder: state and trait features

Shared Differential Factors Underlying Individual Spontaneous Neural Activity Abnormalities in Major Depressive Disorder.

ENIGMA MDD: seven years of global neuroimaging studies of major depression through worldwide data sharing

Multimodal Investigation of Network Level Effects Using Intrinsic Functional Connectivity, Anatomical Covariance, and Structure-to-Function Correlations in Unmedicated Major Depressive Disorder

An empirical analysis of structural neuroimaging profiles in a staging model of depression

Unravelling Robust Brain-Behavior Links of Depressive Symptoms Through Granular Network Models: Understanding Heterogeneity and Clinical Implications

Probing the Clinical and Brain Structural Boundaries of Bipolar and Major Depressive Disorder

Unravelling robust brain-behavior links of depressive complaints through granular network models for understanding heterogeneity

Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo